A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)
Clinical trial NCT04495257 · COMPLETED
Trial details
- NCT number
- NCT04495257
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2026-03-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.